Vertex Pharmaceuticals Inc (VRTX)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 101.31B
P/E Ratio
28.08
Revenue (TTM)
$ 11.42B
Volume
0
52W High
$ 519.88
52W Low
$ 362.50
Dividend Yield
0.00%
Beta
0.44
Technicals
50-Day MA
439.342
200-Day MA
457.2176
52 Week High
519.88
52 Week Low
362.5
About VRTX
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF with.
Employees
6100
Headquarters
Boston, MA
CEO
Dr. Jeffrey Marc Leiden M.D., Ph.D.
Latest News
Environment, Social and Governance (ESG) Risk Ratings
Total ESG Risk Score
30.84
Percentile: 44
Environmental Risk Score
5.65
Percentile: 8
Social Risk Score
24.22
Percentile: 8
Governance Risk Score
12.46
Percentile: 8
Controversy Level
ESG data provided by Sustainalytics, Inc.
VRTX
Category Average
2Moderate Controversy Level
NoneSevere